Nogin Full Year 2022 Earnings EPS Beats Expectations - Yahoo Finance

GNTA Stock  USD 3.80  0.27  6.63%   
About 53% of Genenta Science's investor base is interested to short. The analysis of the overall investor sentiment regarding Genenta Science SpA suggests that many traders are impartial. The current market sentiment, together with Genenta Science's historical and current headlines, can help investors time the market. In addition, many technical investors use Genenta Science SpA stock news signals to limit their universe of possible portfolio assets.
  
Nogin Full Year 2022 Earnings EPS Beats Expectations Yahoo Finance

Read at news.google.com
Google News at Macroaxis
  

Genenta Science Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Genenta Science can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Genenta Science Fundamental Analysis

We analyze Genenta Science's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genenta Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genenta Science based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

Genenta Science is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Genenta Science SpA Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Genenta Science stock to make a market-neutral strategy. Peer analysis of Genenta Science could also be used in its relative valuation, which is a method of valuing Genenta Science by comparing valuation metrics with similar companies.

Peers

Genenta Science Related Equities

ADAGAdagene   6.81   
0%
67.0%
RZLTRezolute   2.42   
0%
23.0%
MLYSMineralys Therapeutics,   1.82   
0%
17.0%
JANXJanux Therapeutics   0.65   
0%
6.0%
OPTOpthea   0.62   
0%
6.0%
PHVSPharvaris   0.59   
0%
5.0%
MOLNMolecular Partners   0.20   
0%
1.0%
PEPGPepGen   0.00   
0%
0%
CSBRChampions Oncology   0.09   
1.0%
0%
AVTEAerovate Therapeutics   0.41   
4.0%
0%
PMVPPmv Pharmaceuticals   0.69   
6.0%
0%
ANTXAN2 Therapeutics   1.74   
17.0%
0%
ANEBAnebulo Pharmaceuticals   4.79   
47.0%
0%
MNOVMediciNova   10.15   
100.0%
0%

Complementary Tools for Genenta Stock analysis

When running Genenta Science's price analysis, check to measure Genenta Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genenta Science is operating at the current time. Most of Genenta Science's value examination focuses on studying past and present price action to predict the probability of Genenta Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genenta Science's price. Additionally, you may evaluate how the addition of Genenta Science to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stocks Directory
Find actively traded stocks across global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device